Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NBP128635E

Novus Biologicals™ Dtk/TYRO3 Antibody Blocking Peptide
SDP

Catalog No. NBP128635E Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.05 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP128635E 0.05 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP128635E Supplier Novus Biologicals™ Supplier No. NBP128635PEP
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

A peptide to TYRO3. The Dtk/TYRO3 Blocking Peptide has been validated for the following applications: Antibody Competition.

Specifications

Gene ID (Entrez) 7301
Species Human
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
Formulation Peptide dissolved in dH2O. Contains no BSA.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NBP1-28635. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias Brt, BYK, DTK, EC 2.7.10, EC 2.7.10.1, FLJ16467, RSE, Sky, Tif, TYRO3 protein tyrosine kinase, Tyrosine-protein kinase byk, Tyrosine-protein kinase DTK, tyrosine-protein kinase receptor TYRO3, Tyrosine-protein kinase RSE, Tyrosine-protein kinase SKY
Gene Symbol TYRO3
Product Type Dtk/TYRO3
Quantity 0.05 mg
Regulatory Status RUO - research use only
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.